TP53 overexpression is an independent adverse prognostic factor in de novo myelodysplastic syndromes with fibrosis

Publisher: John Wiley & Sons Inc

E-ISSN: 1365-2141|171|1|91-99

ISSN: 0007-1048

Source: BRITISH JOURNAL OF HAEMATOLOGY, Vol.171, Iss.1, 2015-10, pp. : 91-99

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract